Cardiac resynchronization therapy: from treatment to prevention.

Christophe Leclercq (1, 2) , Jagmeet P. Singh (3)

1 Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes]
2 CIC-IT Rennes
3 Cardiology Division

This editorial refers to 'Response to preventive cardiac resynchronization therapy in patients with ischaemic and non-ischaemic cardiomyopathy in MADIT-CRT', by A. Barsheshet et al. doi:10.1093/eurheartj/ehq407, 'Timedependent benefit of preventive cardiac resynchronization therapy after myocardial infarction', by A. Barsheshet et al. doi:10.1093/eurheartj/ehq392, and 'Cost-effectiveness of cardiac resyncronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction)', by C. Linde et al. doi:10.1093/eurheartj/ehq408.

Domaines: Ingénierie biomédicale; Cardiologie et système cardiovasculaire

Christophe Leclercq, Jagmeet P. Singh. Cardiac resynchronization therapy: from treatment to prevention.. 2011, ⟨10.1093/eurheartj/ehr016⟩. ⟨hal-00907713⟩